TG Therapeutics Inc (TGTX)

[Ecomike]

The company is alive, and has a large hoard cash now, and a new drug to add to the pipeline, the issue or concern is a possible R/S now or more later, and the convertible shares that represent controlling interest held by the new CEO.

If he converts the shares to common (the stock will crash), and does a R/S (it will crash after the R/S), it may be better to buy at $5/share a few months after the R/S if the R/S happens soon.

If he sits on the R/S for 1-2 years, does not convert the convertibles, then the current float is very low, and could be pushed well over $1/share on news PRs of starting new drug trials, or signing a JV deal, or selling one of the original drugs in the pipeline.